National Institutes of Health/National Cancer Institute (NIH/NCI)
HSSN261200800001E
米国
引用
ジャーナル: Nat Chem Biol / 年: 2023 タイトル: A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins. 著者: Vikas Chonira / Young D Kwon / Jason Gorman / James Brett Case / Zhiqiang Ku / Rudo Simeon / Ryan G Casner / Darcy R Harris / Adam S Olia / Tyler Stephens / Lawrence Shapiro / Michael F ...著者: Vikas Chonira / Young D Kwon / Jason Gorman / James Brett Case / Zhiqiang Ku / Rudo Simeon / Ryan G Casner / Darcy R Harris / Adam S Olia / Tyler Stephens / Lawrence Shapiro / Michael F Bender / Hannah Boyd / I-Ting Teng / Yaroslav Tsybovsky / Florian Krammer / Ningyan Zhang / Michael S Diamond / Peter D Kwong / Zhiqiang An / Zhilei Chen / 要旨: We report the engineering and selection of two synthetic proteins-FSR16m and FSR22-for the possible treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. FSR16m and ...We report the engineering and selection of two synthetic proteins-FSR16m and FSR22-for the possible treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. FSR16m and FSR22 are trimeric proteins composed of DARPin SR16m or SR22 fused with a T4 foldon. Despite selection by a spike protein from a now historical SARS-CoV-2 strain, FSR16m and FSR22 exhibit broad-spectrum neutralization of SARS-CoV-2 strains, inhibiting authentic B.1.351, B.1.617.2 and BA.1.1 viruses, with respective IC values of 3.4, 2.2 and 7.4 ng ml for FSR16m. Cryo-EM structures revealed that these DARPins recognize a region of the receptor-binding domain (residues 456, 475, 486, 487 and 489) overlapping a critical portion of the angiotensin-converting enzyme 2 (ACE2)-binding surface. K18-hACE2 transgenic mice inoculated with B.1.617.2 and receiving intranasally administered FSR16m showed less weight loss and 10-100-fold lower viral burden in upper and lower respiratory tracts. The strong and broad neutralization potency makes FSR16m and FSR22 promising candidates for the prevention and treatment of infection by SARS-CoV-2.
全体 : DARPin SR16m in complex with SARS-CoV-2 RBD and antibody Fabs, S3...
全体
名称: DARPin SR16m in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022
要素
複合体: DARPin SR16m in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022
タンパク質・ペプチド: Anti-SARS-CoV-2 DARPin SR16m
タンパク質・ペプチド: Spike protein S1
タンパク質・ペプチド: Antibody S309 light chain
タンパク質・ペプチド: antibody S309 heavy chain
タンパク質・ペプチド: antibody CR3022 heavy chain
タンパク質・ペプチド: antibody CR3022 light chain
-
超分子 #1: DARPin SR16m in complex with SARS-CoV-2 RBD and antibody Fabs, S3...
超分子
名称: DARPin SR16m in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022 タイプ: complex / ID: 1 / キメラ: Yes / 親要素: 0 / 含まれる分子: all 詳細: DARPin SR16m in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022
由来(天然)
生物種: Severe acute respiratory syndrome coronavirus 2 (SARSコロナウイルス2)